What Makes Pulmonx (LUNG) a New Buy Stock

Pulmonx Corporation (LUNG) has been upgraded to a Zacks Rank #2 (Buy), reflecting an upward trend in its earnings estimates. Specifically, the Zacks Consensus Estimate for the company's fiscal year 2025 earnings has increased by 1% over the past three months. This upgrade positions LUNG in the top 20% of Zacks-covered stocks, signaling a positive earnings outlook that historically correlates with near-term stock price appreciation, driven by institutional investor response to revised earnings forecasts.

Analysis

Pulmonx Corporation (LUNG) has been upgraded to a Zacks Rank #2 (Buy), a signal predicated on positive momentum in earnings estimate revisions. According to the report, the Zacks Consensus Estimate for the company's fiscal year 2025 has risen by 1% over the last three months. This upgrade places the stock in the top 20% of the Zacks-covered universe, which, based on the system's methodology, suggests potential for near-term price appreciation driven by institutional investor activity. However, it is critical to note the underlying figures: the consensus earnings per share (EPS) for fiscal 2025 is projected to be a loss of -$1.51, representing no year-over-year change. Therefore, the positive sentiment is based on a marginal improvement in the expected loss, rather than a fundamental shift towards profitability or earnings growth.

Key Decisions for Investors

• Investors with a short-term, momentum-focused strategy might consider the Zacks Rank #2 upgrade a tactical entry point, as the signal is designed to capture near-term price movements tied to estimate revisions.
• Fundamental investors should remain cautious, weighing the bullish quantitative signal against the fact that Pulmonx is still projected to post a significant loss of -$1.51 per share in fiscal 2025 with no anticipated year-over-year improvement.
• Monitor future analyst estimate revisions closely, as the entire basis for the current 'Buy' rating rests on the positive trajectory of these estimates; any stagnation or reversal in this trend would undermine the investment thesis.